Optimum initial dose of silodosin for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

Optimum initial dose of silodosin for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

We investigated the optimum initial dose and timing of administration of α1A-adrenoceptor antagonist silodosin for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH/LUTS). Ninety-eight patients were given a 4 mg dose after breakfast (group A), 4 mg after sup...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 57(2011), 6 vom: 31. Juni, Seite 297-302
1. Verfasser: Wada, Naoki (VerfasserIn)
Weitere Verfasser: Numata, Atsushi, Yamaguchi, Satoshi, Osanai, Hiroaki, Mori, Tatsuya, Hou, Kyokushin, Fujisawa, Makoto, Kaneko, Shigeo, Kakizaki, Hidehiro
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2011
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Adrenergic alpha-1 Receptor Antagonists Indoles silodosin CUZ39LUY82